FHL5 has recently been identified as a candidate gene in coronary artery disease and myocardial infarction, suggesting its involvement in vascular remodeling and disease risk through transcriptional regulation of downstream gene programs (29). The gene discussed is FHL5; the disease is myocardial infarction.